InTouch Health Partners with Cardiovascular Institute of the South to Offer Telecardiology Services

Published on:

InTouch Health, the leading enterprise telehealth platform, announced today a partnership agreement with Cardiovascular Institute of the South (CIS) to provide remote medical services geared towards emergent and general cardiology expertise in acute settings, adding a fourth service line to the company's physician capacity management offering. CIS will increase breadth and depth of adoption of InTouch Health's services, and extend its cardiology expertise to InTouch Health in two critical ways: (1) addition of cardiologists to InTouch Health's physician capacity management offering, and (2) collaboration on development of workflow solutions to drive best practices and allow for standardized quality of care in telecardiology settings.

"Successful implementation of telemedicine across every point of the patient care continuum – from primary care to acute care to post-acute care to home again – will increase patient safety, improve care quality, address physician shortages, expand access and reduce the cost of high-quality care. Cardiology affects one in four Americans, costs the United States almost $300 billion each year and drives approximately one-third of Medicare costs in this country, so it is prime for disruption and innovation," said Joseph DeVivo, CEO of InTouch Health. "We are excited by CIS' advancements in telecardiology, and are looking forward to our own expanded capabilities within the cardiovascular setting, afforded by this partnership."

"Telemedicine has the ability to transform the way cardiology care is delivered, through expanding access across rural areas, managing bed capacity, easing travel burden on sub-specialties, improving collaboration between sub-specialties and expanding our own coverage internationally," said Craig Walker, MD, founder of CIS. "Our partnership with InTouch Health is going to allow us to take a global approach to the delivery of cardiovascular services and reach patients who currently don't have access to a cardiovascular specialist."

"We see this partnership as a major milestone in our growth strategy," added David Konur, CEO of CIS.

The new partnership will cover emergent cardiology services in the hospital emergency department, as well as more routine consults on an inpatient floor. Boasting cardiologists that represent nearly every specialty in heart and vascular medicine, CIS is at the forefront of advancing the detection, prevention and treatment of cardiovascular disease. CIS hosts a comprehensive heart and vascular program with specialized medical professionals trained in nuclear cardiology, electrophysiology, prevention services and lipid management, as well as interventional cardiovascular procedures.As InTouch Health continues to develop its virtual sub-specialty care model, key partnerships with innovators like CIS and other acute care physician sub-specialists will continue to position InTouch Health as a leading, comprehensive enterprise offering in the telehealth industry. To learn more please visit: www.intouchhealth.com.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”